ORCA
Online Research @ CardiffÂ
Browse by Current Cardiff authors
![[up]](/style/images/multi_up.png)
Up a levelNumber of items: 2.
Champion, Jesse D., Dodd, Kayleigh M., Lam, Hilaire C., Alzahrani, Mohammad A.M., Seifan, Sara, Rad, Ellie, Scourfield, D. Oliver, Fishel, Melissa L., Calver, Brian L., Ager, Ann, Henske, Elizabeth P., Davies, David M., Kelley, Mark R. and Tee, Andrew R.
2022.
Drug inhibition of redox factor-1 restores hypoxic-driven changes in Tuberous Sclerosis Complex 2-deficient cells.
Cancers
|
 
|
Johnson, Charlotte E.  ORCID: https://orcid.org/0000-0003-1954-5142, Dunlop, Elaine A. ORCID: https://orcid.org/0000-0002-9209-7561, Seifan, Sara, McCann, Henry D., Hay, Trevor, Parfitt, Geraint J. ORCID: https://orcid.org/0000-0002-8704-7906, Jones, Ashley T., Giles, Peter J. ORCID: https://orcid.org/0000-0003-3143-6854, Shen, Ming H. ORCID: https://orcid.org/0000-0002-3891-7231, Sampson, Julian R. ORCID: https://orcid.org/0000-0002-2902-2348, Errington, Rachel J. ORCID: https://orcid.org/0000-0002-8016-4376, Davies, D. Mark and Tee, Andrew R. ORCID: https://orcid.org/0000-0002-5577-4631
2018.
Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavirâbortezomib therapy to intensify endoplasmic reticulum stress-induced cell death.
Oncogene
37
, pp. 5913-5925.
10.1038/s41388-018-0381-2
|
|
|
Cardiff University Information Services